Brandon BioCatalyst
Melbournebrandonbiocatalyst.com
Overview
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand, managed by Brandon Capital. It is a collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments, and more than 50 leading medical research institutes and hospitals, focused on developing and commercializing early-stage biomedical discoveries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cytophenix | Sep 2024 | Grant | Co-investor |
| Cytophenix | May 2023 | Grant | Co-investor |
| Amaroq Therapeutics | Jul 2021 | Seed | Co-investor |
| Okogen, Inc. | Feb 2018 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.